Appointment brings extensive operational expertise in supply chain and novel commercial-scale manufacturing systems SOUTH SAN FRANCISCO, Calif., March .
[236 Pages Report] Factors Leading to Worldwide Adoption of Meningococcal Vaccination ProgrammesThe global meningococcal vaccines market is expected to be driven by enhanced access to vaccines in low and middle-income countries, growing investments by manufacturers and governments to cope with pandemic meningitis ou.
BiondVax Pharmaceuticals Ltd. (NASDAQ:NASDAQ:BVXV) Q4 2021 Earnings Conference Call April 04, 2022 10:00 AM ET Company Participants Kenny Green - Edison Group, IR Josh Phillipson - Director.
29.03.2022 - Appointment brings extensive operational expertise in supply chain and novel commercial-scale manufacturing systems SOUTH SAN FRANCISCO, Calif., March 29, 2022 (GLOBE NEWSWIRE) - Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical . Seite 1
[236 Pages Report] The global Meningococcal Vaccines Market is forecast to surpass US$ 3.66 Bn in 2022. With rising prevalence of meningococcal disease worldwide, the overall sales of meningococcal vaccines are slated to rise at a healthy CAGR of 8.6% between 2022 and 2028, reaching a total of around US$ 6 Bn by 20.